Primary Care Clinics in Marion, KS Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 St Luke Medical Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 537 S Freeborn St, Marion, KS 66861 Phone: 620-382-2177 Fax: 620-382-9104 |
Marion Family Physicians Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 537 S Freeborn St, Marion, KS 66861 Phone: 620-382-3722 Fax: 620-382-3851 |
Marion County Rural Health Clinic Llc Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 537 S Freeborn St, Marion, KS 66861 Phone: 620-382-3722 Fax: 620-382-3851 |
News Archive
Doing more harm than good: Scientists uncover harmful effects of dietary supplements
This week, two independent reports highlight the hidden dangers associated with widely available dietary supplements.
New nanometer catalyst filter removes 100% of particle substances of cigarette smoke
The research team led by Dr. Jongsoo Jurng and Dr. Gwi-Nam at KIST stated that, "In cooperation with KT&G, KIST has developed a nano-catalyst filter coated with a manganese oxide-based nano-catalyst, which can be used in a smoking room to reduce and purify major harmful substances of cigarette smoke.
Study explains why the same exercise have different effects in different people
Although everyone can benefit from exercise, the mechanistic links between physical fitness and overall health are not fully understood, nor are the reasons why the same exercise can have different effects in different people.
Chinese SFDA approves Abbott's XIENCE V drug eluting stent for treating coronary artery disease
Abbott (NYSE: ABT) announced today that the Chinese State Food and Drug Administration (SFDA) has approved its XIENCE V(R) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) - the leading cause of death in China. XIENCE V is the only drug eluting stent to have demonstrated superiority over the TAXUS(R) Paclitaxel-Eluting Coronary Stent System (TAXUS) in the primary endpoints of two randomized, pivotal (phase III) clinical trials.
Research roundup: Racial disparities in hospital readmissions; evaluating home oxygen costs; Medicare funding hurdles
Thirty-Day Readmission Rates For Medicare Beneficiaries By Race And Site of Care - Using national Medicare data on 30-day readmissions after hospitalizations for heart attack, congestive heart failure and pneumonia, the authors report that "black patients had 13% higher odds of all-cause 30-day readmission than white patients.
› Verified 5 days ago